CAV1 and non-small cell lung carcinoma: The distribution of the polymorphism of CAV1 rs3779514 in the NSCLC case group was as follows: 433 (92.7%) with CC and 34 (7.3%) with CT + TT; In the control group, there were 349 (88.4%) with CC and 46 (11.6%) with CT + TT.